Word

D DAIICHI

Status

Dead

Status Code

710

Status Date

Friday, July 29, 2016

Serial Number

77665262

Registration Number

3727558

Registration Date

Tuesday, December 22, 2009

Mark Type

3000

Filing Date

Friday, February 6, 2009

Published for Opposition

Tuesday, October 6, 2009

Cancellation Date

Friday, July 29, 2016

Trademark Owner History

DAIICHI SANKYO COMPANY, LIMITED - Original Registrant

Classifications

1 Chemicals for use in the manufacture of pharmaceuticals, cosmetics and food additives, namely, acrinol, D-calcium pantothenate, dexpanthenol, pantethine-A, disodium adenosine triphosphate, epsilon-aminocaproic acid, gamma-aminobutyric acid, pyridoxal 5-phosphate, pyridoxine hydrochloride, sulfadimethoxine, sulfadimethoxine sodium, sulfamonomethoxine sodium, sulpyrine, tranexamic acid, sulfamonomethoxine, P-hydroxyphenyl propionic acid; food preservative compositions; plasticizers for use as high polymer stabilizers for plastics and paint; chemical additives for use in the manufacture of food; chemical antioxidants for use in the manufacture of drinks, cakes, flavoring agents, dairy products and fish paste products; chemical germination inhibitors, namely, gibberellins for grapes, oranges, and domestic and agricultural use; diagnostic reagents for scientific use; diagnostic preparations for in vitro biological tests, namely, for urine and blood test, for blood glucose tests, for clotting tests, all for scientific use; enzyme preparations for in vitro scientific use; soil conditions, namely, soil improving agents and plant growth regulators for agriculture use; chemical preparations in the nature of tetrodotoxins for scientific research use

5 Central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital andrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis, and dermatophytosis, anthelminitics for the treatment of threadworm and toxoplasmosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicide, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment of cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents; preparations for the treatment of hypertension or high blood pressure; preparations for the treatment of diabetes; preparations for antihypertensive agent; preparations for antihypertensive agent combined with a diuretic; preparations for the treatment of ear infections; preparations for treatment of Sjogren's syndrome and/or Xerosis

The color(s) blue, yellow and white is/are claimed as a feature of the mark.
The mark consists of the blue wording "DAIICHI", situated above a blue line which is above a yellow line, all situated to the right of a stylized letter "D" in white inside a blue box.
The English translation of "DAIICHI" in the mark is "first".

Trademark Events

Jul 29, 2016

Cancelled Sec. 8 (6-Yr)

Aug 11, 2015

Attorney Revoked And/Or Appointed

Aug 11, 2015

Teas Revoke/Appoint Attorney Received

Dec 22, 2009

Registered-Principal Register

Oct 6, 2009

Published For Opposition

Sep 16, 2009

Notice Of Publication

Aug 31, 2009

Law Office Publication Review Completed

Aug 28, 2009

Approved For Pub - Principal Register

Aug 28, 2009

Teas/Email Correspondence Entered

Aug 28, 2009

Correspondence Received In Law Office

Aug 27, 2009

Assigned To Lie

Aug 17, 2009

Teas Response To Office Action Received

Mar 24, 2009

Non-Final Action Mailed

Mar 23, 2009

Non-Final Action Written

Mar 19, 2009

Assigned To Examiner

Feb 18, 2009

Teas Change Of Correspondence Received

Feb 11, 2009

Notice Of Design Search Code Mailed

Feb 10, 2009

New Application Office Supplied Data Entered In Tram

Feb 10, 2009

New Application Entered In Tram